Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Monestier

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Efficacy of imiquimod in the management of lentigo malignaMarie Daude, Monica Dinulescu, Jean-Michel Nguyen, et al.
The Oncologist|May 18, 2024
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanomaEmily Connell, Émilie Gerard, Bénédicte Oules, et al.
International Journal of Cancer|January 11, 2021
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational studySandrine Monestier, Stéphane Dalle, Laurent Mortier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell CarcinomaAndrey A Yurchenko, Oltin T Pop, Meriem Ighilahriz, et al.
The Lancet. Oncology|May 31, 2025
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations (EBIN): an international, open-label, randomised, controlled, phase 2 studyCaroline Robert, Michal Kicinski, Caroline Dutriaux, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
International real-world study of combination immunotherapy sequences in metastatic melanomaMora Guardamagna, Sarah E Lochrin, James William Smithy, et al.
BMJ (Clinical Research Ed.)|January 6, 2026
Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trialFranck Boralevi, Guillaume Simon, Charlotte Bernigaud, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Efficacy of imiquimod in the management of lentigo malignaMarie Daude, Monica Dinulescu, Jean-Michel Nguyen, et al.
The Oncologist|May 18, 2024
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanomaEmily Connell, Émilie Gerard, Bénédicte Oules, et al.
International Journal of Cancer|January 11, 2021
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational studySandrine Monestier, Stéphane Dalle, Laurent Mortier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell CarcinomaAndrey A Yurchenko, Oltin T Pop, Meriem Ighilahriz, et al.
The Lancet. Oncology|May 31, 2025
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations (EBIN): an international, open-label, randomised, controlled, phase 2 studyCaroline Robert, Michal Kicinski, Caroline Dutriaux, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
International real-world study of combination immunotherapy sequences in metastatic melanomaMora Guardamagna, Sarah E Lochrin, James William Smithy, et al.
BMJ (Clinical Research Ed.)|January 6, 2026
Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trialFranck Boralevi, Guillaume Simon, Charlotte Bernigaud, et al.
Pageof 2